Targeted Therapy That Works By Enhancing The Body's Own Immune System
Targeted Therapy |
The process of Targeted Therapy involves the identification of specific molecules that are found in
cancer cells. These molecules, which are called biomarkers, are unique to
cancer cells and are not found in healthy cells. Once the biomarkers have been
identified, targeted therapy drugs can be designed to specifically target these
molecules.
There are several different types of Targeted Therapy drugs that are currently available. Some of the
most common include monoclonal antibodies, small molecule inhibitors, and
immune checkpoint inhibitors.
The
Global Targeted Therapy Market Is Estimated To Be Valued At US$ 98.6
Bn In 2021 And Is Expected To Exhibit A CAGR Of 9.0% During The Forecast Period (2021-2028).
Monoclonal antibodies are proteins that are designed to recognize and
attach to specific molecules on the surface of cancer cells. Once attached,
these antibodies can trigger an immune response that leads to the destruction
of the cancer cells.
Small molecule inhibitors, on the other hand, are drugs that are
designed to block specific molecules that are essential for the growth and
survival of cancer cells. By blocking these molecules, the drugs can
effectively stop the growth and spread of cancer cells.
Immune checkpoint inhibitors are a type of Targeted Therapy that works by enhancing the body's own immune
system to recognize and attack cancer cells. These drugs work by blocking
specific proteins that are found on the surface of cancer cells, which can
effectively "unmask" them and allow the immune system to recognize
and attack them.
One of the main benefits of Targeted
Therapy is that it is often more effective and less toxic than traditional
chemotherapy. Because the drugs are designed to only target cancer cells, they
can effectively destroy cancer cells without damaging healthy tissue. This can
lead to fewer side effects and a better quality of life for patients.
Comments
Post a Comment